Who Paid My Doc
Peter Schneider
Vascular Surgery Honolulu, HI Medical Doctor
NPI 1720189640 CMS profile 867531
3288 Moanalua Rd, Honolulu, HI 96819
General payments
$4,816,325
Research payments
$186,976
Ownership & investment interest
$39,522
Research they led as principal investigator
$49,763
Through program year 2025, Peter Schneider of Honolulu, HI is reported in the CMS Open Payments database as having received $4,816,325 across 1,269 general payments and $186,976 in research payments paid to them. Separately, studies naming them as principal investigator received $49,763 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $39,522 across 2 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
15 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $300,403 | 98 | |
| 2025 | Research | $33,056 | 1 | |
| 2024 | General | $630,984 | 181 | |
| 2024 | Research | $50,082 | 2 | |
| 2023 | General | $666,572 | 225 | |
| 2023 | Research | $32,702 | 1 | |
| 2022 | General | $705,051 | 216 | |
| 2022 | Research | $66,637 | 1 | |
| 2021 | General | $703,179 | 144 | |
| 2020 | General | $726,954 | 93 | |
| 2020 | Research | $2,000 | 8 | |
| 2019 | General | $1,083,182 | 312 | |
| 2019 | Research | $2,500 | 8 | |
| 2024 | Ownership | $14,520 | 1 | |
| 2021 | Ownership | $25,002 | 1 |
Beside peers
- Peter Schneider
- Vascular Surgery median
- Middle half of Vascular Surgery
- National median
In program year 2025, general payments to Peter Schneider were reported at $300,403. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.
Show as a table
| Year | Peter Schneider | Vascular Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,083,182 | $796 | $226–$2,363 | $163 |
| 2020 | $726,954 | $348 | $118–$1,110 | $114 |
| 2021 | $703,179 | $471 | $158–$1,421 | $132 |
| 2022 | $705,051 | $725 | $222–$2,183 | $149 |
| 2023 | $666,572 | $836 | $257–$2,440 | $160 |
| 2024 | $630,984 | $909 | $252–$2,619 | $164 |
| 2025 | $300,403 | $924 | $273–$2,636 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
1,290 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Vascular Surgery in Hawaii
Practitioners in the same specialty and state, ranked by reported value.
All Vascular Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Hawaii
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.